Study of KN046 With Chemotherapy in First Line Advanced NSCLC

NCT04054531 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

BIOLOGICAL: KN046
DRUG: Paclitaxel
DRUG: Pemetrexed
DRUG: Carboplatin

Sponsor

Jiangsu Alphamab Biopharmaceuticals Co., Ltd